Over the last four years (2011 to 2014), the percentages of Klebsiella pneumonia e resistant to fluoroquinolones, third-generation cephalosporins and aminoglycosides, as well as combined resistance to all three antimicrobial groups, has increased significantly at the EU/EEA level.

This report is based on data for 2014 retrieved from The European Surveillance System (TESSy) on 19 February 2018.

This report is based on data for 2015 retrieved from The European Surveillance System (TESSy) on 19 February 2018.

This report is based on data for 2016 retrieved from The European Surveillance System (TESSy) on 19 February 2018.

Twenty-seven countries, comprising 25 EU Member States and two EEA countries (Iceland and Norway) reported data on antimicrobial consumption for 2017.

 Annual Epidemiological Report Chlamydia for 2014

For 2017, no cases of Lassa fever or other infections by arenaviruses responsible for viral haemorrhagic fevers were reported in the EU/EEA.

Cholera is a rare travel-associated disease in the EU/EEA. In 2016, six EU/EEA countries reported 23 laboratory-confirmed cases of cholera, which was in the range of previous years. All cases with known travel history were infected outside of Europe.

This edition of the Annual Report gives special attention to vaccine-preventable diseases and immunisation programmesin the European Union (EU) and European Economic Area (EEA) countries. This edition was revised January and June 2010 and has authority over the print edition.

In 2016, 28 countries reported 6 918 confirmed yersiniosis cases in the EU/EEA.